{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:37:33Z","timestamp":1790915853491,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,27]],"date-time":"2010-10-27T00:00:00Z","timestamp":1288137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1038\/npp.2010.192","type":"journal-article","created":{"date-parts":[[2010,10,27]],"date-time":"2010-10-27T14:07:30Z","timestamp":1288188450000},"page":"375-389","source":"Crossref","is-referenced-by-count":215,"title":["Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials"],"prefix":"10.1038","volume":"36","author":[{"given":"Ay\u015feg\u00fcl","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross J","family":"Baldessarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,27]]},"reference":[{"key":"BFnpp2010192_CR1","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.317.7168.1309","volume":"317","author":"DG Altman","year":"1988","unstructured":"Altman DG (1988). Confidence intervals for the number needed to treat. BMJ 317: 1309\u20131312.","journal-title":"BMJ"},{"key":"BFnpp2010192_CR2","unstructured":"American Psychiatric Association (APA) (2000). Diagnostic and Statistical Manual, 4th edn, text revision. American Psychiatric Association: Washington, DC."},{"key":"BFnpp2010192_CR3","unstructured":"AstraZeneca (2010). Multicenter, double-blind, randomized, parallel-group, placebo controlled, phase III study of the efficacy and safety of quetiapine fumarate (Seroquel\u00ae) sustained-release as monotherapy in adult patients with acute bipolar mania. Study ID Number: D144CC00004. ClinicalTrials.gov: NCT00422123 AstraZeneca (Data on file)."},{"key":"BFnpp2010192_CR4","first-page":"461","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"RJ Baldessarini","year":"2005","unstructured":"Baldessarini RJ, Tarazi FI (2005). Pharmacotherapy of psychosis and mania. In: Brunton LL, Lazo JS, Parker KL (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edn. McGraw-Hill Press: New York, pp 461\u2013500."},{"key":"BFnpp2010192_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/00006842-196311000-00005","volume":"25","author":"LS Benjamin","year":"1963","unstructured":"Benjamin LS (1963). Statistical treatment of the law of initial values (LIV) in autonomic research: a review and recommendation. Psychosom Med 25: 556\u2013566.","journal-title":"Psychosom Med"},{"key":"BFnpp2010192_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00004850-199911000-00003","volume":"14","author":"M Berk","year":"1999","unstructured":"Berk M, Ichim L, Brook S (1999). Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 14: 339\u2013343.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFnpp2010192_CR7","volume-title":"American Psychiatric Association 162nd Annual Meeting","author":"J Berwaerts","year":"2009","unstructured":"Berwaerts J, Xu H, Nuamah I, Lim P, Hough D (2009). Randomized, double-blind, placebo-controlled, dose-response study of paliperidone ER for acute manic and mixed episodes in bipolar I disorder. ClinicalTrials.gov: NCT00299715. American Psychiatric Association 162nd Annual Meeting. San Francisco, CA."},{"key":"BFnpp2010192_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009). Introduction to meta-analysis, 1st edn. John Wiley & Sons Ltd: West Sussex, UK."},{"key":"BFnpp2010192_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","volume":"271","author":"CL Bowden","year":"1994","unstructured":"Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F et al, Depakote Mania Study Group (1994). Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 271: 918\u2013924.","journal-title":"JAMA"},{"key":"BFnpp2010192_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/YIC.0b013e3282fd827c","volume":"23","author":"CL Bowden","year":"2008","unstructured":"Bowden CL, G\u00f6\u011f\u00fc\u015f A, Grunze H, H\u00e4ggstr\u00f6m L, Rybakowski J, Vieta E (2008). A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode. Int Clin Psychopharmacol 23: 254\u2013262.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFnpp2010192_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4088\/JCP.v66n0116","volume":"66","author":"CL Bowden","year":"2005","unstructured":"Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M et al (2005). A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 66: 111\u2013121.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","volume":"67","author":"CL Bowden","year":"2006","unstructured":"Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA et al, Depakote ER Mania Study Group (2006). Randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 67: 1501\u20131510.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/hup.1095","volume":"25","author":"F Centorrino","year":"2010","unstructured":"Centorrino F, Ventriglio A, Vincenti A, Talamo A, Baldessarini RJ (2010). Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Hum Psychopharmacol 25: 179\u2013186.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp2010192_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s11064-008-9817-3","volume":"34","author":"YC Chang","year":"2009","unstructured":"Chang YC, Rapoport SI, Rao JS (2009). Chronic administration of mood stabilizers upregulates BDNF and Bcl-2 expression levels in rat frontal cortex. Neurochem Res 34: 536\u2013541.","journal-title":"Neurochem Res"},{"key":"BFnpp2010192_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R Der Simonian","year":"1986","unstructured":"Der Simonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7: 177\u2013188.","journal-title":"Control Clin Trials"},{"key":"BFnpp2010192_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie's R (2000). Trim and fill: a simple funnel-plot-based methof of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455\u2013463.","journal-title":"Biometrics"},{"key":"BFnpp2010192_CR17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.euroneuro.2010.07.003","volume":"20","author":"RS El Mallakh","year":"2010","unstructured":"El Mallakh RS, Vieta E, Rollin L, Marcus R, Carson WH, McQuade R (2010). A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations. Study ID Number: CN138\u2013007. Eur Neuropsychopharmacol 20: 776\u2013783.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2010192_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0924-977X(96)00029-6","volume":"6","author":"G Emilien","year":"1996","unstructured":"Emilien G, Maloteaux JM, Seghers A, Charles G (1996). Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis. Eur Neuropsychopharmacol 6: 245\u2013252.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2010192_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","volume":"35","author":"J Endicott","year":"1978","unstructured":"Endicott J, Spitzer RL (1978). A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35: 837\u2013844.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010192_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.2009.1943","volume":"303","author":"JC Fournier","year":"2010","unstructured":"Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC et al (2010). Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA 303: 47\u201353.","journal-title":"JAMA"},{"key":"BFnpp2010192_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1176\/ajp.149.1.108","volume":"149","author":"TW Freeman","year":"1992","unstructured":"Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC (1992). A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 149: 108\u2013111.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010192_CR22","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2165\/00003495-200363190-00009","volume":"63","author":"DR Goldsmith","year":"2003","unstructured":"Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM (2003). Lamotrigine: a review of its use in bipolar disorder. Drugs 63: 2029\u20132050.","journal-title":"Drugs"},{"key":"BFnpp2010192_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4088\/JCP.08m04960yel","volume":"71","author":"RM Hirschfeld","year":"2010","unstructured":"Hirschfeld RM, Bowden CL, Vigna NV, Wozniak P, Collins M (2010). A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the acute treatment of mania. ClinicalTrials.gov: NCT00060905. J Clin Psychiatry 71: 426\u2013432.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR24","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","volume":"161","author":"RM Hirschfeld","year":"2004","unstructured":"Hirschfeld RM, Keck Jr PE, Kramer M, Karcher K, Canuso C, Eerdekens M et al (2004). Rapid antimanic effect of risperidone monotherapy: 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 161: 1057\u20131065.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010192_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/10401230009147081","volume":"12","author":"L Ichim","year":"2000","unstructured":"Ichim L, Berk M, Brook S (2000). Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 12: 5\u201310.","journal-title":"Ann Clin Psychiatry"},{"key":"BFnpp2010192_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1176\/ajp.155.7.972","volume":"155","author":"PG Janicak","year":"1998","unstructured":"Janicak PG, Sharma RP, Pandey G, Davis JM (1998). Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. Am J Psychiatry 155: 972\u2013973.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010192_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.eurpsy.2008.12.014","volume":"24","author":"AK Kakkar","year":"2009","unstructured":"Kakkar AK, Rehan HS, Unni KES, Gupta NK, Chopra D, Kataria D (2009). Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. Eur Psychiatry 24: 178\u2013182.","journal-title":"Eur Psychiatry"},{"key":"BFnpp2010192_CR28","volume-title":"International College of Neuropsychopharmacology","author":"H Katagiri","year":"2010","unstructured":"Katagiri H, Takita Y, Tohen M, Takahashi M (2010). Efficacy and safety of olanzapine in the treatment of Japanese patients with manic or mixed episode of bipolar I disorder: A multicenter, randomized, double-blind, parallel, placebo- and haloperidol-controlled study. ClinicalTrials.gov: NCT00129220. International College of Neuropsychopharmacology, 27th Annual Congress Hong Kong, China."},{"key":"BFnpp2010192_CR29","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","volume":"160","author":"PE Keck Jr","year":"2003","unstructured":"Keck Jr PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A et al, Aripiprazole Study Group (2003a). A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160: 1651\u20131658.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010192_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","volume":"112","author":"PE Keck","year":"2009","unstructured":"Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN et al, CN138\u2013135 Study Group (2009). Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord 112: 36\u201349.","journal-title":"J Affect Disord"},{"key":"BFnpp2010192_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","volume":"160","author":"PE Keck Jr","year":"2003","unstructured":"Keck Jr PE, Versiani M, Potkin S, West SA, Giller E, Ice K, Ziprasidone in Mania Study Group (2003b). Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 160: 741\u2013748.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010192_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1192\/bjp.187.3.229","volume":"187","author":"S Khanna","year":"2005","unstructured":"Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M (2005). Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 187: 229\u2013234.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010192_CR33","volume-title":"American Psychiatric Association","author":"MA Knesevich","year":"2009","unstructured":"Knesevich MA, Wang O, Papadakis K, Korotzer A, Bose A, Laszlovszky I (2009). The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. ClinicalTrials.gov: NCT00488618. American Psychiatric Association, 162nd Annual Meeting. San Francisco, CA."},{"key":"BFnpp2010192_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","volume":"8","author":"SF Kushner","year":"2006","unstructured":"Kushner SF, Khan A, Lane R, Olson WH (2006). Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. ClinicalTrials.gov: NCT00037674; NCT00240721; NCT00035230. Bipolar Disord 8: 15\u201327.","journal-title":"Bipolar Disord"},{"key":"BFnpp2010192_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/sj.mp.4002136","volume":"14","author":"S Leucht","year":"2009","unstructured":"Leucht S, Arbter D, Engel RR, Kissling W, Davis JM (2009). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry 14: 429\u2013447.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2010192_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1185\/030079908X253933","volume":"24","author":"H Li","year":"2008","unstructured":"Li H, Ma C, Wang G, Zhu X, Peng M, Gu N (2008). Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study. ClinicalTrials.gov: NCT00448578. Curr Med Res Opin 24: 1\u201310.","journal-title":"Curr Med Res Opin"},{"key":"BFnpp2010192_CR37","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S0006-3223(00)00979-3","volume":"48","author":"HK Manji","year":"2000","unstructured":"Manji HK, Moore GJ, Chen G (2000). Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 48: 740\u2013754.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2010192_CR38","first-page":"142","volume":"57","author":"SL McElroy","year":"1996","unstructured":"McElroy SL, Keck PE, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM (1996). A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 57: 142\u2013146.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR39","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","volume":"15","author":"RS McIntyre","year":"2005","unstructured":"McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J (2005). Quetiapine or haloperidol as monotherapy for bipolar mania: 12-week, double-blind, randomized, parallel-group, placebo-controlled trial. Eur Neuropsychopharmacol 15: 573\u2013585.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2010192_CR40","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1399-5618.2009.00749.x","volume":"11","author":"RS McIntyre","year":"2009","unstructured":"McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J (2009a). Asenapine versus olanzapine in acute mania: a double-blind extension study. Bipolar Disord 11: 815\u2013826.","journal-title":"Bipolar Disord"},{"key":"BFnpp2010192_CR41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","volume":"11","author":"RS McIntyre","year":"2009","unstructured":"McIntyre RS, Cohen M, Zhao J, Alphs L, Macek TA, Panagides J (2009b). A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states. Bipolar Disord 11: 673\u2013686.","journal-title":"Bipolar Disord"},{"key":"BFnpp2010192_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/bmj.331.7509.155","volume":"331","author":"J Moncrieff","year":"2005","unstructured":"Moncrieff J, Kirsch I (2005). Efficacy of antidepressants in adults. BMJ 331: 155\u2013157.","journal-title":"BMJ"},{"key":"BFnpp2010192_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jad.2007.04.020","volume":"105","author":"G Niufan","year":"2008","unstructured":"Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H et al (2008). Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. ClinicalTrials.gov: NCT00485680. J Affect Disord 105: 101\u2013108. (Originally published as e-pub ahead of print May 24, 2007).","journal-title":"J Affect Disord"},{"key":"BFnpp2010192_CR44","unstructured":"Novartis Clinical Trial Results Database (2007). A randomized, double-blind, placebo-controlled multicenter study to evaluate efficacy and tolerability of licabazepine 1000\u20132000\u2009mg\/d in the treatment of manic episodes of bipolar I disorder over 3 weeks. Study ID Number: CLIC477D2301. ClinicalTrials.gov: NCT00099229. Novartis (Data on file)."},{"key":"BFnpp2010192_CR45","first-page":"157","volume":"8","author":"RG Orwin","year":"1983","unstructured":"Orwin RG (1983). A fail-safe N for effect-size in meta-analysis. J Ed Stat 8: 157\u2013159.","journal-title":"J Ed Stat"},{"key":"BFnpp2010192_CR46","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.4088\/JCP.v67n1112","volume":"67","author":"RH Perlis","year":"2006","unstructured":"Perlis RH, Baker RW, Zarate Jr CA, Brown EB, Schuh LM, Jamal HH et al (2006a). Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. J Clin Psychiatry 67: 1747\u20131753.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4088\/JCP.v67n0401","volume":"67","author":"RH Perlis","year":"2006","unstructured":"Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck Jr PE (2006b). Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 67: 509\u2013516.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","volume":"48","author":"HG Pope Jr","year":"1991","unstructured":"Pope Jr HG, McElroy SL, Keck Jr PE, Hudson JI (1991). Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 48: 62\u201368.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010192_CR49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","volume":"25","author":"SG Potkin","year":"2005","unstructured":"Potkin SG, Keck Jr PE, Segal S, Ice K, English P (2005). Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 25: 301\u2013310.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp2010192_CR50","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/0269881106059693","volume":"20","author":"G Sachs","year":"2006","unstructured":"Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W et al, Aripiprazole Study Group (2006). Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol 20: 536\u2013546.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2010192_CR51","unstructured":"Sanofi-Aventis (2007). A twelve-week, open, randomized trial comparing valproate to lithium in Bipolar I patients suffering from a manic episode. Study ID Numbers: R_8740. ClinicalTrials.gov: NCT00264173. Sanofi-C (Data on file)."},{"key":"BFnpp2010192_CR52","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/archpsyc.64.4.442","volume":"4","author":"H Scherk","year":"2007","unstructured":"Scherk H, Pajonk FG, Leucht S Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry, 2007 4: 442\u2013455.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010192_CR53","first-page":"176","volume":"21","author":"J Segal","year":"1998","unstructured":"Segal J, Berk M, Brook S (1998). Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21: 176\u2013180.","journal-title":"Clin Neuropharmacol"},{"key":"BFnpp2010192_CR54","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archpsyc.1991.01810340047006","volume":"48","author":"JG Small","year":"1991","unstructured":"Small JG, Klapper MH, Milstein V, Kellams JJ, Miller MJ, Marhenke JD et al (1991). Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 48: 915\u2013921.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010192_CR55","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","volume":"9","author":"LA Smith","year":"2007","unstructured":"Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D (2007). Pharmacological interventions for acute bipolar mania: systematic review of randomized placebo-controlled trials. Bipolar Disord 9: 551\u2013560.","journal-title":"Bipolar Disord"},{"key":"BFnpp2010192_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","volume":"15","author":"AB Smulevich","year":"2005","unstructured":"Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F (2005). Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol 15: 75\u201384.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2010192_CR57","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","volume":"35","author":"RL Spitzer","year":"1978","unstructured":"Spitzer RL, Endicott J, Robins E (1978). Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35: 773\u2013882.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010192_CR58","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JAC Sterne","year":"2001","unstructured":"Sterne JAC, Egger M (2001). Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clinical Epidemiology 54: 1046\u20131055.","journal-title":"J Clinical Epidemiology"},{"key":"BFnpp2010192_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","volume":"323","author":"JAC Sterne","year":"2001","unstructured":"Sterne JAC, Egger M, Smith GD (2001). Investigating and dealing with publication and other biases in meta-analysis. BMJ 323: 101\u2013105.","journal-title":"BMJ"},{"key":"BFnpp2010192_CR60","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","volume":"159","author":"M Tohen","year":"2002","unstructured":"Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA et al (2002). Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 159: 1011\u20131017.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010192_CR61","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC et al (2003). A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry 60: 1218\u20131226.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010192_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","volume":"57","author":"M Tohen","year":"2000","unstructured":"Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG et al, Olanzipine HGGW Study Group (2000). Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 57: 841\u2013849.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010192_CR63","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","volume":"156","author":"M Tohen","year":"1999","unstructured":"Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KN, Daniel DG et al, Olanzapine HGEH Study Group (1999). Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 156: 702\u2013709.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2010192_CR64","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.4088\/JCP.v69n1113","volume":"69","author":"M Tohen","year":"2008","unstructured":"Tohen M, Vieta E, Goodwin G, Sun B, Amsterdam J, Banov M et al (2008). Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: randomized, 12-week, double-blind study. J Clin Psychiatry 69: 1776\u20131789.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR65","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-0327(00)00162-2","volume":"65","author":"M Tohen","year":"2001","unstructured":"Tohen M, Zhang F, Taylor CC, Burns P, Zarate C, Sanger T et al (2001). A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. J Affect Disord 65: 85\u201393.","journal-title":"J Affect Disord"},{"key":"BFnpp2010192_CR66","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jad.2009.02.007","volume":"118","author":"E Vieta","year":"2009","unstructured":"Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board (2009). Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). J Affect Disord 118: 118\u2013123.","journal-title":"J Affect Disord"},{"key":"BFnpp2010192_CR67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1192\/bjp.187.3.235","volume":"187","author":"E Vieta","year":"2005","unstructured":"Vieta E, Bourin M, Sanchez R, Marcus R, Stock E, McQuade R et al, Aripoprazole Study Group (2005). Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Br J Psychiatry 187: 235\u2013242.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010192_CR68","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4088\/JCP.v69n0423g","volume":"69","author":"E Vieta","year":"2008","unstructured":"Vieta E, Cruz N (2008). Increasing rates of placebo response over time in mania studies. J Clin Psychiatry 69: 681\u2013682.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR69","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1399-5618.2010.00815.x","volume":"12","author":"E Vieta","year":"2010","unstructured":"Vieta E, Nuamah IF, Lim P, Yuen EC, Palumbo JM, Hough DW et al (2010a). A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder. ClinicalTrials.gov: NCT00309699. Bipolar Disord 12: 230\u2013243.","journal-title":"Bipolar Disord"},{"key":"BFnpp2010192_CR70","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0269881108099418","volume":"24","author":"E Vieta","year":"2010","unstructured":"Vieta E, Ramey T, Keller D, English PA, Loebel AD, Miceli J (2010b). Ziprasidone in the treatment of acute mania: 12- week placebo-controlled, haloperidol-referenced study. J Psychopharmacol 24: 547\u2013558. (Originally published as e-pub ahead of print December 12, 2008).","journal-title":"J Psychopharmacol"},{"key":"BFnpp2010192_CR71","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4088\/JCP.v65n0405","volume":"65","author":"RH Weisler","year":"2004","unstructured":"Weisler RH, Kalali AH, Ketter TA, SPD417 Study Group (2004). A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 65: 478\u2013484.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR72","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4088\/JCP.v66n0308","volume":"66","author":"RH Weisler","year":"2005","unstructured":"Weisler RH, Keck Jr PE, Swann AC, Cutler AJ, Ketter TA, Kalali AH, SPD417 Study Group (2005). Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 66: 323\u2013330.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR73","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/cc1548","volume":"6","author":"E Whitley","year":"2002","unstructured":"Whitley E, Ball J (2002). Statistics review 5: Comparison of means. Crit Care 6: 424\u2013428.","journal-title":"Crit Care"},{"key":"BFnpp2010192_CR74","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","volume":"65","author":"A Yildiz","year":"2008","unstructured":"Yildiz A, Guleryuz S, Ankerst DP, Ong\u00fcr D, Renshaw PF (2008). Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 65: 255\u2013263.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2010192_CR75","volume-title":"European College of Neuropsychopharmacology","author":"A Yildiz","year":"2010","unstructured":"Yildiz A, Vieta E, Tohen M, Baldessarini RJ (2010). Placebo-related response in clinical trials for bipolar mania: what is driving this phenomenon and what can be done to minimize it? European College of Neuropsychopharmacology, 23rd Annual Congress Breaking News Symposia: Amsterdam, Netherlands."},{"key":"BFnpp2010192_CR76","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","volume":"194","author":"AH Young","year":"2009","unstructured":"Young AH, Oren DA, Lowy A, McQuade RD, Marcus RN, Carson WH et al (2009). Aripiprazole monotherapy in acute mania: a 12-week, randomized placebo- and haloperidol-controlled study. Br J Psychiatry 194: 40\u201348.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010192_CR77","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133: 429\u2013435.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2010192_CR78","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.4088\/JCP.v63n1210","volume":"63","author":"JM Zajecka","year":"2002","unstructured":"Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW (2002). A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 63: 1148\u20131155.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2010192_CR79","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1399-5618.2007.00530.x","volume":"9","author":"CA Zarate Jr","year":"2007","unstructured":"Zarate Jr CA, Singh JB, Carlson PJ, Quiroz J, Jolkovsky L, Luckenbaugh DA et al (2007). Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 9: 561\u2013570.","journal-title":"Bipolar Disord"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2010192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2010192","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2010192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T01:29:00Z","timestamp":1685842140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2010192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,27]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["BFnpp2010192"],"URL":"https:\/\/doi.org\/10.1038\/npp.2010.192","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,27]]}}}